Nitazoxanide ( DrugBank: Nitazoxanide )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	1

96. クローン病

---

臨床試験数 : 2,400 /  薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00130390 (ClinicalTrials.gov)	August 2005	12/8/2005	Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease	Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults	Crohn's Disease	Drug: Nitazoxanide;Other: Placebo	Romark Laboratories L.C.	NULL	Terminated	18 Years	N/A	Both	98	Phase 2	United States

97. 潰瘍性大腸炎

---

臨床試験数 : 2,527 /  薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03441893 (ClinicalTrials.gov)	January 1, 2015	8/2/2018	Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis	Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis	Ulcerative Colitis;Ulcerative Colitis Exacerbation;Protozoan Infections;Helminth Infection	Diagnostic Test: parasitological diagnostics (coproscopy);Drug: Nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg	Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan	NULL	Active, not recruiting	18 Years	90 Years	All	300	Phase 1/Phase 2	NULL